Literature DB >> 2610686

Sphingolipid hydrolase activator proteins and their precursors.

A Sano1, T Hineno, T Mizuno, K Kondoh, S Ueno, Y Kakimoto, K Inui.   

Abstract

Activator proteins for sphingolipid hydrolases (saposins) are small acidic, heat-stable glycoproteins that stimulate the hydrolysis of sphingolipids by lysosomal enzymes. The molecular mass of each stimulator is about 10 kDa, but glycosylated forms of higher mass exist too. The distribution and developmental changes in two saposins and their precursor proteins were studied with the aid of monospecific antibodies against saposin-B and saposin-C. They show a wide distribution in rat organs and forms intermediate between saposin and prosaposin (the precursor protein containing four different saposin units) could be seen. The amount of saposin and the degree of processing from prosaposin are quite different in different tissues. The saposins are the dominant forms in spleen, lung, liver, and kidney, while skeletal muscle, heart, and brain contain mainly precursor forms. In human blood, leukocytes contain mainly saposin, while plasma contains mainly precursor forms and platelets show many forms. Their subcellular distribution was studied using rat liver. The saposins of approximately 20 kDa are dominant in the light mitochondrial, mitochondrial, and microsomal fractions, following the distribution of the activity of a lysosomal marker enzyme. The nuclear fraction exhibits bands corresponding to non-glycosylated saposin. The soluble fraction contained much precursor forms. A developmental study of rat brain showed that the concentration of saposin precursors increased with age.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610686     DOI: 10.1016/0006-291x(89)92728-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).

Authors:  D Wrobe; M Henseler; S Huettler; S I Pascual Pascual; A Chabas; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.

Authors:  B C Paton; B Schmid; B Kustermann-Kuhn; A Poulos; K Harzer
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 3.  Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka
Journal:  Anat Sci Int       Date:  2021-02-03       Impact factor: 1.741

Review 4.  The immunological functions of saposins.

Authors:  Alexandre Darmoise; Patrick Maschmeyer; Florian Winau
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 5.  The role of saposin C in Gaucher disease.

Authors:  Rafael J Tamargo; Arash Velayati; Ehud Goldin; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2012-05-05       Impact factor: 4.797

6.  Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides.

Authors:  A Haltia; M L Solin; H Jalanko; C Holmberg; A Miettinen; H Holthöfer
Journal:  Histochem J       Date:  1996-10

7.  The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Authors:  Tsadok Cohen; Wojtek Auerbach; Liat Ravid; Jacques Bodennec; Amos Fein; Anthony H Futerman; Alexandra L Joyner; Mia Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Identification of prosaposin as a neurotrophic factor.

Authors:  J S O'Brien; G S Carson; H C Seo; M Hiraiwa; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Occurrence of prosaposin as a neuronal surface membrane component.

Authors:  Q Fu; G S Carson; M Hiraiwa; M Grafe; Y Kishimoto; J S O'Brien
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

10.  Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1.

Authors:  Soo-Young Kang; Ole J Halvorsen; Karsten Gravdal; Nandita Bhattacharya; Jung Min Lee; Nathan W Liu; Brian T Johnston; Adam B Johnston; Svein A Haukaas; Kristie Aamodt; Sun Yoo; Lars A Akslen; Randolph S Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.